Tamara Redondo-Diaz
Malaga, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Real-world effectiveness and safety of Sacituzumab Govitecan in metastatic triple-negative breast cancer: results from the multicenter retrospective observational SACISUR cohort in Southern Spain.
Journal: Frontiers in oncology
Published: October 01, 2025
Identification and Management of Medical Comorbidities in Patients With HR+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: Literature Review and Recommendations From Experts in Spain Opinion.
Journal: Clinical breast cancer
Published: July 07, 2024
Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study.
Journal: Breast (Edinburgh, Scotland)
Published: May 24, 2024
Role of poly-ADP-ribose polymerase inhibitors after brain progression in platinum-sensitive ovarian cancer: a case report and review of the literature.
Journal: Frontiers in oncology
Published: April 26, 2024
ATM Variant as a Cause of Hereditary Cutaneous Melanoma in a Spanish Family: Case Report.
Journal: Case reports in oncology
Published: November 15, 2023
XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease.
Journal: Breast cancer research : BCR
Published: January 04, 2023
Machine learning and natural language processing (NLP) approach to predict early progression to first-line treatment in real-world hormone receptor-positive (HR+)/HER2-negative advanced breast cancer patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 19, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026